<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E6E6F0D2-BFAC-48CF-9920-335191A3B88E"><gtr:id>E6E6F0D2-BFAC-48CF-9920-335191A3B88E</gtr:id><gtr:name>University of Brasilia</gtr:name><gtr:address><gtr:line1>Campus Universitario Darcy Ribeiro</gtr:line1><gtr:line4>Brasilia - DF</gtr:line4><gtr:line5>CEP 70910-900</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Physiology Development and Neuroscience</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E6E6F0D2-BFAC-48CF-9920-335191A3B88E"><gtr:id>E6E6F0D2-BFAC-48CF-9920-335191A3B88E</gtr:id><gtr:name>University of Brasilia</gtr:name><gtr:address><gtr:line1>Campus Universitario Darcy Ribeiro</gtr:line1><gtr:line4>Brasilia - DF</gtr:line4><gtr:line5>CEP 70910-900</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5F0D9936-B03D-44DA-9BCB-79B34E3EB785"><gtr:id>5F0D9936-B03D-44DA-9BCB-79B34E3EB785</gtr:id><gtr:firstName>Angela</gtr:firstName><gtr:surname>Roberts</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901884"><gtr:id>E73683BF-BD62-4524-99E9-0F8781A9690A</gtr:id><gtr:title>Neurobiological and Neurochemical mechanisms underlying emotional regulation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901884</gtr:grantReference><gtr:abstractText>Emotions are highly adaptive and complex states, which include our internal feelings, e.g. happiness or fear, our physiological reactions, e.g. sweaty palms, racing heart, and our behavioural responses e.g. approaching something nice and avoiding something harmful. They are triggered by stimuli in the environment, that through past experience, have gained emotional significance. However, our immediate reactions to such emotive stimuli are not always beneficial, and we need to be able to adapt and rapidly modify our emotional responses on a moment-by-moment basis, whether it?s in the workplace, or at home. The ability to regulate our emotions is essential for our physiological, psychological and social well-being and when this ability is impaired it can have a profound, deleterious impact on us. This is illustrated by the range of neuropsychiatric disorders in which emotional disturbance is a core feature, including anxiety, depression, schizophrenia, autism and sociopathy. Anxiety disorders alone have a lifetime prevalence of 16%. It has been shown that in many of these neuropsychiatric disorders there is pathology in various regions of the brain, including the orbitofrontal cortex and amygdala. In addition, there are also imbalances in a number of chemical messengers in the brain, including serotonin. Indeed, many drugs used to treat these neuropsychiatric disorders, target serotonin. However, exactly how these brain regions contribute to emotional regulation, and the role played by serotonin, is poorly understood. We will investigate this by modelling their effects in the brains of experimental animals performing behavioural tests that measure their ability to regulate their emotions. The benefits provided by this Programme lie eventually in understanding how these different regions of the brain control our emotions and how serotonin modulates these brain regions. This information is critical for our ability to develop novel therapies, as well as target current therapies more effectively, for a range of neuropsychiatric</gtr:abstractText><gtr:technicalSummary>Emotions are highly adaptive and complex states, simultaneously engaging psychological, physiological and behavioral responses that are triggered by the appraisal of external events. However, our immediate reactions to emotive stimuli are not always beneficial, and therefore, an important element of emotion is the ability to appropriately adapt and rapidly modify emotional responses on a moment-by-moment basis. That such regulation is essential for the physiological, psychological and social health of the individual is clearly illustrated by the range of neuropsychiatric disorders in which emotional dysregulation is a core feature, including anxiety, depression, schizophrenia, autism and sociopathy. In all of these disorders there is neuropathology or neurochemical imbalances in neural circuitry that includes the amygdala and orbitofrontal cortex (OFC). Defining the underlying mechanisms by which this orbitofrontal-amygdala circuit contributes to distinct aspects of affective processing will help us to understand the underlying behavioural and social deficits in these disorders. It will also help us to develop new treatments and target current treatments more effectively. 
This Programme will investigate the neural and neurochemical substrates of emotional regulation focussing on the OFC and the amygdala and their modulation by the neurotransmitter, serotonin. Major components of emotions are the physiological responses that accompany behaviour including autonomic, neuroendocrine and somatic. These changes in the internal state of the body anticipate, facilitate and accommodate the consequences of our actions. Thus, key cardiovascular variables, namely heart rate and blood pressure will be monitored alongside behaviour. We hypothesise that distinct elements of the orbitofrontal-amygdala circuit are involved in regulating our emotional reactions to cues in the environment that predict appetitive and aversive stimuli, as well as in regulating our instrumental actions, guided by those cues, to obtain or avoid such stimuli. We will assess the role of distinct sub-regions of the OFC in these different aspects of regulation and determine whether such processing is independent, or not, of affective valence. We will also identify the key role played by serotonin, both at the level of the OFC and at the level of the amygdala, in modulating these different aspects of regulation in both the appetitive and the aversive domain. Particular attention will be paid to how dysfunction within the orbitofrontal-amygdala circuit contributes to anxiety and whether changes in serotonergic modulation of this circuit underlie individual differences in anxiety.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1278442</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Brasilia</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Brasilia</gtr:description><gtr:id>75A70C4C-0611-46D6-B89D-78E759EE8D86</gtr:id><gtr:impact>Exchange of techniques</gtr:impact><gtr:outcomeId>5458ac2ad99126.45720407-1</gtr:outcomeId><gtr:partnerContribution>Access to data, equipment and facilities</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC neurochemist training Programme II</gtr:description><gtr:id>27DC7007-A990-4741-8E28-1B32586C388F</gtr:id><gtr:impact>not yet started</gtr:impact><gtr:outcomeId>pKbtGVfzEAn-1</gtr:outcomeId><gtr:partnerContribution>My partners will be developing and providing the mgluR5 ligand, 18F[FPEB] and will also be performing all the analyses.</gtr:partnerContribution><gtr:piContribution>We will be investigating the relationship of mgluR5 receptor binding in target brain regions including orbitofrontal cortex, insula and ventral striatum, with trait anxiety.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wolfson Brain Imaging Centre</gtr:department><gtr:description>MRC neurochemist training programme</gtr:description><gtr:id>6CE1FA69-F524-4F0D-863B-545035D23EDD</gtr:id><gtr:impact>Society for Neuroscience poster 2012</gtr:impact><gtr:outcomeId>LxbmoNVyFah-1</gtr:outcomeId><gtr:partnerContribution>They provided the 5-HT2a receptor ligand, 18F altanserin, and performed the analyses of the dataset.</gtr:partnerContribution><gtr:piContribution>We investigated 5-HT2a receptor binding distribution in the brains of marmosets with different alleles of the serotonin transporter gene and related this to trait anxiety.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1560000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme grant</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>089589/Z/09/Z</gtr:fundingRef><gtr:id>C11CCF0A-2082-43C5-B073-1AC1A0A1A2E3</gtr:id><gtr:outcomeId>NRVy9dToduW</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2021861</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Investigator award</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>108089/Z/15/Z</gtr:fundingRef><gtr:id>893991DD-EC51-428C-BF34-2A3CCBC98535</gtr:id><gtr:outcomeId>564a428b2897b2.02339772</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Council of Understanding Animal Research</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>241035BF-23A1-441F-92B0-7A2EDFDB5BAF</gtr:id><gtr:impact>Understanding Animal Research provides information and educational materials based on thorough research and understanding of the facts, historical and scientific.

Understanding Animal Research seeks to engage with and inform many sectors to bring about its vision. Key stakeholders include members of the public, the media, policy makers, schools and the scientific research community.</gtr:impact><gtr:outcomeId>5458b7065df665.13570635</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.understandinganimalresearch.org.uk/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>microPET imaging to measure dopamine D2 receptors and serotonin 5-HT2a receptors in anaethetised animals.</gtr:description><gtr:id>3BCFAA93-A394-44B4-9C13-D0F40BB539CA</gtr:id><gtr:impact>Expansion of experimental research approaches for addressing scientific questions into the regulation of emotion and its neural underpinnings.</gtr:impact><gtr:outcomeId>VZScdJKLk91</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>microPET measurement of D2 and 5-HT2a receptors</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24872570</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A method for measuring the reactivity of the hypothalamic-pituitary axis, highly relevant to our understanding of human mood and anxiety disorders.</gtr:description><gtr:id>45D701DB-5BEC-4AFF-BEFC-798663ABD6F1</gtr:id><gtr:impact>A more thorough analysis of emotionality in marmosets.</gtr:impact><gtr:outcomeId>miVUqu2tgNa</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dexamethasone suppression test</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MicroPET imaging using 18FDG to measure functional activity across brain regions related to behavioural processes</gtr:description><gtr:id>3A0E0733-79E8-4023-B7DB-B89A5FC61CE8</gtr:id><gtr:impact>This new approach will open up a whole new set of questions that we can address in our research</gtr:impact><gtr:outcomeId>tqbsrFSuFxg</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>MicroPET to measure functional activity</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a method to infuse radioactive ligand directly into the jugular vein of marmosets but using a subcutaneous port implant so the marmoset receives minimal discomfort.</gtr:description><gtr:id>C7F67236-DF90-48EA-9FC7-03CDFEECA41C</gtr:id><gtr:impact>It allows us to perform microPET imaging measuring FluoroDexoxyGlucose uptake as a measure of brain activity in freely moving marmosets.</gtr:impact><gtr:outcomeId>58b9a01cd2cd23.19668515</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>port implant</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Measure of emotional function using a non invasive procedure.</gtr:description><gtr:id>31A26CAE-9BF7-4D14-81FD-853AE70C2147</gtr:id><gtr:impact>Provide more in depth analysis of emotional function.</gtr:impact><gtr:outcomeId>RBr4FKc2y6V</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cortisol from saliva</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A functional polymorphism has been identified in animals relevant to our understanding of trait anxiety and mood and anxiety disorders.</gtr:description><gtr:id>12E98BA1-595F-4FBE-A5A9-AA419FD7125D</gtr:id><gtr:impact>This opens up a whole new approach to studying the genetic and neurobiological underpinnings of mood and anxiety disorders.</gtr:impact><gtr:outcomeId>ig4XQ15xy3Y</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Serotonin transporter polymorphism in animals</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Characterisation of behavioural responses related to anxiety using Principle Components analysis</gtr:description><gtr:id>BA28A761-3046-4EAB-BEC0-CAB5706B7E39</gtr:id><gtr:impact>A more robust measure of anxiety</gtr:impact><gtr:outcomeId>djj7kGznPUn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Measurement of anxiety</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22502990</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>670572DC-214B-4984-896F-3BF30072B7B5</gtr:id><gtr:title>Opposing effects of 5,7-DHT infusions into the orbitofrontal cortex and amygdala on flexible responding.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9e296919bc0050486443532433027ae"><gtr:id>f9e296919bc0050486443532433027ae</gtr:id><gtr:otherNames>Man MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>QfA3yhEH4iM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>164968BC-102A-47F7-B2E9-425442A00A9C</gtr:id><gtr:title>A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey.</gtr:title><gtr:parentPublicationTitle>Developmental neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6df1bdd6a742f853d8d490aa2271ddeb"><gtr:id>6df1bdd6a742f853d8d490aa2271ddeb</gtr:id><gtr:otherNames>Oikonomidis L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-8451</gtr:issn><gtr:outcomeId>58b98b209770f6.49512760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5C2C500-EC85-4731-8483-CC32123AE97E</gtr:id><gtr:title>Dissociable roles for lateral orbitofrontal cortex and lateral prefrontal cortex during preference driven reversal learning.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24479313b0eedf22c2282573c763f5eb"><gtr:id>24479313b0eedf22c2282573c763f5eb</gtr:id><gtr:otherNames>Hampshire A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>HUsyyWUChJ5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80F89107-E9F5-401A-AEA4-92415E3843D2</gtr:id><gtr:title>Role of Central Serotonin in Anticipation of Rewarding and Punishing Outcomes: Effects of Selective Amygdala or Orbitofrontal 5-HT Depletion.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afda288f4b3435a4943241550f5b7d23"><gtr:id>afda288f4b3435a4943241550f5b7d23</gtr:id><gtr:otherNames>Rygula R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>5458a955d33cb0.69569164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26E42526-4413-47AD-A6D2-2FB4278AB161</gtr:id><gtr:title>Individual differences in behavioral and cardiovascular reactivity to emotive stimuli and their relationship to cognitive flexibility in a primate model of trait anxiety.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18c736475c4748a1f16a6d063eb249d3"><gtr:id>18c736475c4748a1f16a6d063eb249d3</gtr:id><gtr:otherNames>Shiba Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>5458a7eee6d3c4.49230074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D42439DE-78A6-4B6A-9461-E93D9E176055</gtr:id><gtr:title>Serotonergic, brain volume and attentional correlates of trait anxiety in primates.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ef8aa44c94805d8d3eaaffa31c7347b"><gtr:id>0ef8aa44c94805d8d3eaaffa31c7347b</gtr:id><gtr:otherNames>Mikheenko Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>doi_55f9859853f1dc7d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75BD8DB7-2C90-42A2-8724-99DEE70FDAA5</gtr:id><gtr:title>Beyond the Medial Regions of Prefrontal Cortex in the Regulation of Fear and Anxiety.</gtr:title><gtr:parentPublicationTitle>Frontiers in systems neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18c736475c4748a1f16a6d063eb249d3"><gtr:id>18c736475c4748a1f16a6d063eb249d3</gtr:id><gtr:otherNames>Shiba Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1662-5137</gtr:issn><gtr:outcomeId>56cc5fa1113cd8.90699511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60D9BBD6-19C0-4F53-A78F-95BC0CAE23D6</gtr:id><gtr:title>The importance of serotonin for orbitofrontal function.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b273d3049e466373321c66c56bf4400d"><gtr:id>b273d3049e466373321c66c56bf4400d</gtr:id><gtr:otherNames>Roberts AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>J33VxbhDXvQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02AC9670-7C61-4088-B6C5-D3502D1CCAA3</gtr:id><gtr:title>Autonomic, behavioral, and neural analyses of mild conditioned negative affect in marmosets.</gtr:title><gtr:parentPublicationTitle>Behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ef8aa44c94805d8d3eaaffa31c7347b"><gtr:id>0ef8aa44c94805d8d3eaaffa31c7347b</gtr:id><gtr:otherNames>Mikheenko Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0735-7044</gtr:issn><gtr:outcomeId>Sme2AAx2Lnp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F198CC53-0E02-48A6-AB67-8D0AFA115112</gtr:id><gtr:title>Regional inactivations of primate ventral prefrontal cortex reveal two distinct mechanisms underlying negative bias in decision making.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d3ae7b0f559bda4fc815311855c0c45"><gtr:id>5d3ae7b0f559bda4fc815311855c0c45</gtr:id><gtr:otherNames>Clarke HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>564a3c53bc3c88.60659479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F801D4-0D73-4AA8-B657-02726B0C290C</gtr:id><gtr:title>Contribution of the amygdala, but not orbitofrontal or medial prefrontal cortices, to the expression of flavour preferences in marmoset monkeys.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b175ed70e2f4e64434807995f1926859"><gtr:id>b175ed70e2f4e64434807995f1926859</gtr:id><gtr:otherNames>Agust?n-Pav?n C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>raxMvBQJMSx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96B8FDD9-A3CC-488E-9CE6-0B563B5126B4</gtr:id><gtr:title>Lesions of either anterior orbitofrontal cortex or ventrolateral prefrontal cortex in marmoset monkeys heighten innate fear and attenuate active coping behaviors to predator threat.</gtr:title><gtr:parentPublicationTitle>Frontiers in systems neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18c736475c4748a1f16a6d063eb249d3"><gtr:id>18c736475c4748a1f16a6d063eb249d3</gtr:id><gtr:otherNames>Shiba Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1662-5137</gtr:issn><gtr:outcomeId>564a3c538e2689.27335154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05A5EE2F-5E43-4244-8004-2C00776BCE55</gtr:id><gtr:title>Lesions of ventrolateral prefrontal or anterior orbitofrontal cortex in primates heighten negative emotion.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b175ed70e2f4e64434807995f1926859"><gtr:id>b175ed70e2f4e64434807995f1926859</gtr:id><gtr:otherNames>Agust?n-Pav?n C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_15933_23_22502990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DE4168B-E3EA-4775-824F-BE534C248798</gtr:id><gtr:title>Serotonin at the level of the amygdala and orbitofrontal cortex modulates distinct aspects of positive emotion in primates.</gtr:title><gtr:parentPublicationTitle>The international journal of neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9e296919bc0050486443532433027ae"><gtr:id>f9e296919bc0050486443532433027ae</gtr:id><gtr:otherNames>Man MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1461-1457</gtr:issn><gtr:outcomeId>5458a9fb9c28f9.57866119</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901884</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>